BridgeBio Oncology Therapeutics, Inc. (BBOT) Capital expenditures 2024–2025
BridgeBio Oncology Therapeutics, Inc. (BBOT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$606,000FY2025 · since FY2024: $49,000 → $606,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $606,000 | +1136.7% |
| FY2024 | $49,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice